AUG 04, 2019 8:04 AM PDT

The anti-cancer flower

Perhaps you have heard of feverfew, a quite common flowering plant that graces many home gardens. Its cute white petals may bring a smile to your lips – but did you know that it has hidden within it an anti-cancer compound?

New research from the University of Birmingham and published in MedChemComm shows that in addition to acting as a natural remedy for fevers, migraine headaches, rheumatoid arthritis, stomach aches, and toothaches, among other symptoms, feverfew is also capable of killing chronic lymphocytic leukaemia (CLL) cells.

Researchers from the University's Institute of Cancer and Genomic Studies, the School of Chemistry and the drug discovery services companies, Sygnature Discovery and Apconix collaborated with the University of Birmingham's Winterbourne Botanic Garden to cultivate enough feverfew plants to conduct the study. While previous studies had identified the compound found in the plant, called parthenolide, it is currently only available commercially at an outrageously high price and still not very effective.

The research team wanted to change that so they set out to find a way to produce the parthenolide directly from plants, as well as a way to alter it so that the plant produces several other compounds that were shown to kill cancer cells in in vitro experiments. While still only demonstrated in a laboratory setting, the finding could have significant impacts on development of treatments for chronic lymphocytic leukaemia (CLL) therapies.

A researcher on the study, Dr. Angelo Agathanggelou, of the Institute of Cancer and Genomic Studies, clarified: "There are several effective treatments for CLL, but after a time the disease in some patients becomes resistant. We were interested in finding out more about the potential of parthenolide. With expertise from colleagues in the School of Chemistry we've been able to demonstrate that this compound shows real promise and could provide alternative treatment options for CLL patients."

Inside feverfew hides a compound with anti-cancer properties. Photo: Pixabay

Another researcher on the study, Professor John Fossey, commented: "This research is important not only because we have shown a way of producing parthenolide that could make it much more accessible to researchers, but also because we've been able to improve its "drug-like" properties to kill cancer cells. It's a clear demonstration that parthenolide has the potential to progress from the flowerbed into the clinic."

Parthenolide works by raising the levels of reactive oxygen species (ROS) in cells, essentially pushing ROS levels to an unsustainable level in cancer cells until the cell cannot survive and dies.

Sources: Science Daily, MedChemComm

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
AUG 19, 2021
Cancer
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
AUG 19, 2021
Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth
Early-onset colorectal cancer progresses in the same way as average onset colorectal cancer. The corresponding study was ...
AUG 30, 2021
Cancer
A Hot Approach to CAR T Cells
AUG 30, 2021
A Hot Approach to CAR T Cells
Immunotherapy, a type of treatment that targets a patient’s immune system to enhance the natural ability to attack ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 24, 2021
Microbiology
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
OCT 24, 2021
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
Bacteria can be found almost everywhere, and they can serve many beneficial purposes. Scientists are now using bacterial ...
Loading Comments...